Sitagliptin Comparative Study in Patients With Type 2 Diabetes (0431-049)

PHASE3CompletedINTERVENTIONAL

Enrollment

1,050

Participants

Timeline

Start Date

March 1, 2007

Primary Completion Date

July 25, 2008

Study Completion Date

July 25, 2008

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

sitagliptin phosphate

(1) sitagliptin 100mg tablet once daily (q.d.) for a 24-wk treatment period

DRUG

Comparator: metformin hydrochloride

(4) Metformin 500mg tablets once daily (q.d.) for a 24-wk treatment period.

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00449930 - Sitagliptin Comparative Study in Patients With Type 2 Diabetes (0431-049) | Biotech Hunter | Biotech Hunter